Phase 3 Primary Biliary Cholangitis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You must be willing and able to sign and date a consent form agreeing to take part in the study
• You must have previously taken part in the fenofibrate study for PBC (a specific earlier clinical trial, reference NCT02823353)
• If you are a woman who could become pregnant, you must agree to use at least one barrier method of contraception (such as a condom or diaphragm) plus one additional form of birth control during the study and for at least 90 days after your last dose
• If you are a man who is sexually active with a woman who could become pregnant, you must use a barrier method of contraception, and your partner must also use an additional form of birth control during the study and for at least 90 days after the last dose

Who may not be able to join:

• You had to stop taking fenofibrate during the previous study because of a side effect from the treatment
• You have another serious health condition (such as cancer) that, in the doctor's opinion, would prevent you from fully taking part in the study or affect the results
• You have a known history of other liver diseases (besides PBC)
• You are currently pregnant or breastfeeding (for women)
• You have been taking immune-suppressing medications long-term
• You have any other condition that the study doctor believes could put your safety at risk or affect the quality of the study results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.